Benefícios da dieta com baixo índice glicêmico no controle da glicemia e perda ponderal de pacientes com Diabetes Mellitus tipo 2: Revisão sistemática de ensaios clínicos randomizados
DOI:
https://doi.org/10.47320/rasbran.2021.1235Palavras-chave:
Diabetes Mellitus tipo 2, Controle Glicêmico, Dieta de baixo índice glicêmico, Perda ponderalResumo
Objetivos: Analisar os benefícios das dietas de baixo índice glicêmico no controle da glicemia e perda ponderal de diabéticos do tipo 2. Métodos: Realizou-se levantamento da literatura científica relacionada ao tema nos últimos 10 anos nas bases de dados Scielo, Bireme, Cochraine Library e Pubmed, obtendo um total de 13 ensaios clínicos randomizados. Resultados: Houve relação entre dieta de baixo índice glicêmico e controle da glicemia, representado pela HbA1C e perda ponderal em indivíduos com DM2. Os estudos analisados obtiveram resultados com grandes diferenças devido às várias dietas utilizadas como comparação, além de serem estudos no limiar de qualidade metodológica relevante. Conclusão: Faz-se necessário estudos melhores delineados para identificar o real efeito da dieta de baixo índice glicêmico no controle da glicemia e perda de peso de indivíduos com DM2.
Downloads
Referências
Borges DB, Lacerda JT. Ações voltadas ao controle do Diabetes Mellitus na Atenção Básica: proposta de modelo avaliativo. Saúde Debate. 2018; 42(116): 162-178. Disponível em: http://www.scielo.br/pdf/sdeb/v42n116/0103-1104-sdeb-42-116-0162.pdf DOI: https://doi.org/10.1590/0103-1104201811613
International Diabetes Federation. IDF Atlas. 8º ed. Brussels, Belgium: International Diabetes Federation; 2017.
Prasad RB, Groop L. Genetics of Type 2 Diabetes—Pitfalls and Possibilities. Genes (Basel).2015; 6(1): 87–123. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377835/pdf/genes-06-00087.pdf DOI: https://doi.org/10.3390/genes6010087
Skyler JS, Bakris GL, Bonifacio E, Darsow T, Eckel RH, Groop L. Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis. Diabetes.2017;66(2):241-255.Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384660/ DOI: https://doi.org/10.2337/db16-0806
Jin B, Liu R, Hao S, Li Z, Zhu C, Zhou X. Defining and characterizing the critical transition state prior to the type 2 diabetes disease. PLoS One. 2017;12(7): e0180937. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501620/ DOI: https://doi.org/10.1371/journal.pone.0180937
Bertoldi AD, Kanavos P, França GV, Carraro A, Tejada CA, Hallal PC. Epidemiology, management, complications and costs associated with type 2 diabetes in Brazil: a comprehensive literature review. Global Health.2013;9:62. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220809/ DOI: https://doi.org/10.1186/1744-8603-9-62
Lima CLJ, Ferreira TMC, Oliveira PS, Ferreira JDL, Silva EC, Costa MML. Caracterização de usuários em risco de desenvolver diabetes: um estudo transversal. Rev Bras Enferm. 2018;71(1):475-82. Disponível em: http://www.scielo.br/pdf/reben/v71s1/pt_0034-7167-reben-71-s1-0475.pdf DOI: https://doi.org/10.1590/0034-7167-2017-0776
Bhupathiraju S, Tobias DK, Malik VS, Pan A, Hruby A, Mason JE. Glycemic index, glycemic load, and risk of type 2 diabetes: results from 3 large US cohorts and an updated meta-analysis. Am J Clin Nutr. 2014;100(1)218-32. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4144100/ DOI: https://doi.org/10.3945/ajcn.113.079533
Aziz A, Dumais L, Barber J. Health Canada’s evaluation of the use of glycemic index claims on food labels. Am J Clin Nutr. 2013; 98(2):269-74. Disponível em: https://academic.oup.com/ajcn/article/98/2/269/4577119 DOI: https://doi.org/10.3945/ajcn.113.061770
Jadad, AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DL. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1-12. Disponível em: https://pdfs.semanticscholar.org/8308/34cccb0e42f08fd760e03ce3e8b54011edba.pdf DOI: https://doi.org/10.1016/0197-2456(95)00134-4
Jenkins DJ, Kendall CW, McKeown-Eyssen G, Josse RG, Silverberg J, Booth GL. Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes: a randomized trial. JAMA.2008;300(23)2742-53. Disponível em: https://jamanetwork.com/journals/jama/fullarticle/183081 DOI: https://doi.org/10.1001/jama.2008.808
Westman EC, Yancy WS Jr, Mavropoulos JC, Marquart M, McDuffie JR. The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2 diabetes mellitus. Nutr Metab (Lond).2008;5:36.Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2633336/ DOI: https://doi.org/10.1186/1743-7075-5-36
Wolever TM, Gibbs AL, Mehling C, Chiasson JL, Connelly PW, Josse RG.The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein. Am J Clin Nutr. 2008;87(1):114-25. Disponível em: https://academic.oup.com/ajcn/article/87/1/114/4633211 DOI: https://doi.org/10.1093/ajcn/87.1.114
Yunsheng Ma, Olendzki BC, Merriam PA, Chiriboga DE, Culver BSP, Li W. A Randomized Clinical Trial Comparing Low-Glycemic Index versus ADA Dietary Education among Individuals with Type 2 Diabetes.Nutrition.2008;24(1):45-56. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2330083/ DOI: https://doi.org/10.1016/j.nut.2007.10.008
Yusof BN, Talib RA, Kamaruddin NA, Karim NA, Chinna K, Gilbertson H. A low-GI diet is associated with a short-term improvement of glycaemic control in Asian patients with type 2 diabetes. Diabetes Obes Metab.2009;11(4):387-96. DOI: https://doi.org/10.1111/j.1463-1326.2008.00984.x
Miller CK, Gutschall M. A randomized trial about glycemic index and glycemic load improves outcomes among adults with type 2 diabetes. Health Educ Behav.2009;36(3):615-26. DOI: https://doi.org/10.1177/1090198108317598
Reis CEG, Diullius J. Glycemic acute changes in type 2 diabetics caused by low and high glycemic index diets. Nutr Hosp.2011;26(3):546-52. Disponível em: https://www.ncbi.nlm.nih.gov/pubmed/21892573
Fabricatore NA, Wadden TA, Ebbeling CB, Thomas JG, Stallings VA, Schwartz S. Targeting dietary fat or glycemic load in the treatment of obesity and type 2 diabetes: a randomized controlled trial. Diabetes Res Clin Pract. 2011; 92(1):37-45.Disponível em: https://www.ncbi.nlm.nih.gov/pubmed/21208675 DOI: https://doi.org/10.1016/j.diabres.2010.12.016
Jenkins DJ, Srichaikul K, Kendall CWC, Sievenpiper JL, Abdulnour S, Mirrahimi A. The relation of low glycaemic index fruit consumption to glycaemic control and risk factors for coronary heart disease in type 2 diabetes. Diabetologia.2011;54(2)271-279. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017317/ DOI: https://doi.org/10.1007/s00125-010-1927-1
Visek J, Lacigova S, Cechurova D, Rusavy Z. Comparison of a low-glycemic index vs standard diabetic diet. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub.2014;158(1):112-6. Disponível em: http://biomed.papers.upol.cz/pdfs/bio/2014/01/17.pdf DOI: https://doi.org/10.5507/bp.2012.103
Jenkins DJ, Kendall CW, Augustin LS, Mitchell S, Sahye-Pudaruth S,Blanco Mejia S. Effect of legumes as part of a low glycemic index diet on glycemic control and cardiovascular risk factors in type 2 diabetes mellitus: a randomized controlled trial. Arch Intern Med.2012;172(21):1653-60. Disponível em: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/1384247 DOI: https://doi.org/10.1001/2013.jamainternmed.70
Wang ML, Gellar L, Nathanson BH, Pbert L, Ma Y, Ockene I. Decrease in Glycemic Index Associated with Improved Glycemic Control among Latinos with Type 2 Diabetes. J Acad Nutr Diet.2015;115(6):898-906. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450120/ DOI: https://doi.org/10.1016/j.jand.2014.10.012
Wolever TM, Chiasson JL, Josse RG, Leiter LA, Maheux P, Rabasa-Lhoret R. Effects of Changing the Amount and Source of Dietary Carbohydrates on Symptoms and Dietary Satisfaction Over a 1-Year Period in Subjects with Type 2 Diabetes: Canadian Trial of Carbohydrates in Diabetes (CCD). Can J Diabetes.2017;41(2):164-176. DOI: https://doi.org/10.1016/j.jcjd.2016.08.223
Via MA, Mechanick JI. Nutrition in Type 2 Diabetes and Metabolic Sydrome. Med Clin North Am.2016;100(6)1285-1302. Disponível em: https://www.medical.theclinics.com/article/S0025-7125(16)37300-X/pdf DOI: https://doi.org/10.1016/j.mcna.2016.06.009
Ohara M, Fukui T, Ouchi M, Watanabe K, Suzuki T, Yanamoto S. Relationship between daily and day-to-day glycemic variability and increased oxidative stress in type 2 diabetes. Diabetes Res Clin Pract.2016; 122:62-70. Disponível em: https://www.diabetesresearchclinicalpractice.com/article/S0168-8227(16)30677-5/fulltext DOI: https://doi.org/10.1016/j.diabres.2016.09.025
Exebio JC, Zarini GG, Vaccaro JA, Exebio C, Huffman FG. Use of hemoglobin A1C to detect Haitian-Americans with undiagnosed Type 2 diabetes. Arq Bras Endocrinol Metab.2012;56(7):449-455. Disponível em: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27302012000700007&lang=pt DOI: https://doi.org/10.1590/S0004-27302012000700007
Xu F, Zhao LH, Su JB, Chen T, Wang XQ, Chen JF. The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c. Diabetol Metab Syndr. 2014; 6(1):139. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4272789/ DOI: https://doi.org/10.1186/1758-5996-6-139
Garvey WT, Ryan DH, Bohannon NJ, Kushner RF, Rueger M, Dvorak RV. Weght-loss therapy in type 2 diabetes: effects of phentermine and topiramate extended release. Diabetes Care.2014;37(12):3309-16.Disponível em: http://care.diabetesjournals.org/content/37/12/3309.long DOI: https://doi.org/10.2337/dc14-0930
Gomes JMG, Fabrini SP, Alfenas RCG. Low glycemic index diet reduces body fat and attenuates inflammatory and metabolic responses in patients with type 2 diabetes. Arch Endocrinol Metab. 2017;61(2):137-144. Disponível em: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972016005004101&lng=en&nrm=iso&tlng=e DOI: https://doi.org/10.1590/2359-3997000000206
Parrinello CM, Selvin E. Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management. Curr Diab Rep.2014;14(11):548. Disponível em:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214073
Yuan C, Lai CWK, Chan LWC, Chow M, Lew HKW, Ying M. The Effect of Diabetes Self-Management Education on Body Weight, Glycemic Control, and Other Metabolic Markers in Patients with Type 2 Diabetes Mellitus. J Diabetes Res.2014; 2014:789761. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127232/ DOI: https://doi.org/10.1155/2014/789761
Parrinello CM, Selvin E. Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management. Curr Diab Rep.2014;14(11):548. Disponível em:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214073 DOI: https://doi.org/10.1007/s11892-014-0548-3
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2022 Revista da Associação Brasileira de Nutrição - RASBRAN
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
A Revista se reserva no direito de efetuar, se necessário, alterações de ordem normativa, ortográfica e gramatical, com vistas a manter o padrão culto da língua, respeitando, porém, o estilo dos autores.
Ao encaminhar os originais, os autores cedem os direitos de primeira publicação para a Revista da Associação Brasileira de Nutrição e aceitam que seu trabalho seja publicado de acordo com nossa Declaração de Direito Autoral.
Os documentos publicados serão atribuídos a licença 
Este trabalho está licenciado com uma Licença Creative Commons - Atribuição 4.0 Internacional.
